Literature DB >> 29052434

A virtual clinic improves pneumococcal vaccination coverage among patients living with HIV at a Veterans Affairs Medical Center.

Charles M Burns1, Richard E Banks2, Brigid M Wilson2, Rebecca R Carter3, Robin L P Jump2,3,4, Federico Perez2,4.   

Abstract

People living with the human immunodeficiency virus (HIV) should receive pneumococcal vaccinations as part of their routine health maintenance. Our goal was to create a "virtual clinic" to help increase rates of pneumococcal vaccination among people living with HIV without adding substantially to the workload of primary providers. We used administrative data from our Veterans Affairs (VA) medical center to identify a cohort of veterans living with HIV who were not current with either the 13-valent pneumococcal conjugate vaccine (PCV13), the 23-valent pneumococcal polysaccharide vaccine (PPSV23) or both. We enrolled these individuals (n = 99) into a virtual clinic, notified providers via the electronic medical record and mailed letters to the veterans recommending they receive a pneumococcal vaccine. We also wrote orders for the appropriate pneumococcal vaccine that expired after 90 days. Among the virtual clinic cohort, 38% (38/99) of patients received the recommended vaccine within 180 days. Concurrent with our intervention, the Veterans Health Administration deployed a system-wide pneumococcal vaccine clinical reminder that incorporated recent PCV13 recommendations. To discern any effect of the virtual clinic beyond that of the clinical reminder, we compared the rate of PCV13 vaccinations among all HIV-positive veterans at our institution to the equivalent population from 2 other VA medical centers in Ohio. With consideration of the VHA's system-wide clinical reminder, the proportion of HIV-positive patients who received PCV13 in the first 90 days following the virtual clinic intervention was greater at our facility compared to another Ohio VA medical center (P < 0.05). The virtual clinic improved the pneumococcal vaccine coverage among HIV-positive veterans. These outcomes suggest that even in conjunction with a system-wide clinical reminder, the virtual clinic strategy improves vaccination rates among a high-risk population.

Entities:  

Keywords:  13-valent pneumococcal vaccines; 23-valent pneumococcal capsular polysaccharide vaccine; Human immunodeficiency virus; electronic health record; immunization; pneumococcal vaccines

Mesh:

Substances:

Year:  2017        PMID: 29052434      PMCID: PMC5846095          DOI: 10.1080/09540121.2017.1390542

Source DB:  PubMed          Journal:  AIDS Care        ISSN: 0954-0121


  13 in total

1.  Barriers to influenza immunization in a low-income urban population.

Authors:  K Armstrong; M Berlin; J S Schwartz; K Propert; P A Ubel
Journal:  Am J Prev Med       Date:  2001-01       Impact factor: 5.043

2.  Prevention of invasive pneumococcal disease among HIV-infected adults in the era of childhood pneumococcal immunization.

Authors:  Adam L Cohen; Lee H Harrison; Monica M Farley; Arthur L Reingold; James Hadler; William Schaffner; Ruth Lynfield; Ann R Thomas; Michael Campsmith; Jianmin Li; Anne Schuchat; Matthew R Moore
Journal:  AIDS       Date:  2010-09-10       Impact factor: 4.177

3.  Predictors for and coverage of influenza vaccination among HIV-positive patients: a cross-sectional survey.

Authors:  N Harrison; W Poeppl; H Herkner; K D Tillhof; K Grabmeier-Pfistershammer; A Rieger; C Forstner; H Burgmann; H Lagler
Journal:  HIV Med       Date:  2016-12-30       Impact factor: 3.180

4.  Meeting the Challenges of Immunizing Adults.

Authors:  Carolyn B Bridges; Laura P Hurley; Walter W Williams; Aparna Ramakrishnan; Anna K Dean; Amy V Groom
Journal:  Am J Prev Med       Date:  2015-09-14       Impact factor: 5.043

5.  U.S. physicians' perspective of adult vaccine delivery.

Authors:  Laura P Hurley; Carolyn B Bridges; Rafael Harpaz; Mandy A Allison; Sean T O'Leary; Lori A Crane; Michaela Brtnikova; Shannon Stokley; Brenda L Beaty; Andrea Jimenez-Zambrano; Faruque Ahmed; Craig Hales; Allison Kempe
Journal:  Ann Intern Med       Date:  2014-02-04       Impact factor: 25.391

6.  Effectiveness of polysaccharide pneumococcal vaccine in HIV-infected patients: a case-control study.

Authors:  Maria Peñaranda; Vicenç Falco; Antoni Payeras; Queralt Jordano; Adria Curran; Antoni Pareja; Gloria Samperiz; David Dalmau; Esteve Ribera; Melcior Riera
Journal:  Clin Infect Dis       Date:  2007-08-21       Impact factor: 9.079

7.  Factors associated with vaccination of medicare beneficiaries in five U.S. communities: Results from the racial and ethnic adult disparities in immunization initiative survey, 2003.

Authors:  Carla A Winston; Pascale M Wortley; Karen A Lees
Journal:  J Am Geriatr Soc       Date:  2006-02       Impact factor: 5.562

Review 8.  Housing Status, Medical Care, and Health Outcomes Among People Living With HIV/AIDS: A Systematic Review.

Authors:  Angela A Aidala; Michael G Wilson; Virginia Shubert; David Gogolishvili; Jason Globerman; Sergio Rueda; Anne K Bozack; Maria Caban; Sean B Rourke
Journal:  Am J Public Health       Date:  2015-11-12       Impact factor: 9.308

9.  Standing orders for influenza and pneumococcal polysaccharide vaccination: correlates identified in a national survey of U.S. Primary care physicians.

Authors:  Steven M Albert; Mary Patricia Nowalk; Michael A Yonas; Richard K Zimmerman; Faruque Ahmed
Journal:  BMC Fam Pract       Date:  2012-03-20       Impact factor: 2.497

10.  General practitioners' experiences, attitudes, and opinions regarding the pneumococcal vaccination for adults: a qualitative study.

Authors:  Nina Badertscher; Seraina Morell; Thomas Rosemann; Ryan Tandjung
Journal:  Int J Gen Med       Date:  2012-11-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.